Home > About Us > History

About Us

History

1947

Kosei Suisan K.K. established in Minato-ku, Tokyo.

Kurihama Plant opens in Kanagawa.


1950

Industrial production of chondroitin sulfate as a pharmaceutical begins.


1952

Head Office relocated to Chuo-ku, Tokyo.


1953

Name of company changed to K.K. Seikagaku Kenkyusho.


1960

Tokyo Research Institute opens in Shinjuku-ku, Tokyo.

Development and marketing of research biochemicals begins.


1962

Name of company changed to Seikagaku Corporation.


1968

Tokyo Research Institute relocated to Higashiyamato-shi, Tokyo.


1975

Takahagi Plant opens in Ibaraki.


1981

World's first endotoxin colorimetry reagent developed and manufactured.


1987

Marketing begins for hyaluronic acid formulations ARTZ and OPEGAN.


1989

Company stock registered with the Japan Securities Dealers Association (Now JASDAQ).


1992

Overseas marketing of ARTZ begins (Sweden).


1993

Marketing begins for ARTZ Dispo, a new formulation.


1997

Acquisition of Associates of Cape Cod, Inc. (U.S.A.)


1998

Quality Management System certification ISO 9001/EN 46001, ISO 13485 obtained (superseded by ISO 13485 certification since 2010).


2000

Name of Tokyo Research Institute changed to Central Research Laboratories.


2001

Marketing begins for hyaluronic acid formulation SUPARTZ in U.S.A.


2004

Listing moved to the Tokyo Stock Exchange, Second Section.


2005

Listing moved to the Tokyo Stock Exchange, First Section.

Head Office relocated to Chiyoda-ku, Tokyo.


2007

Marketing begins for a hyaluronic acid medical device MucoUp.

Seikagaku Biobusiness Corporation established.


2012

Marketing begins for a single injection hyaluronic acid formulation Gel-One in U.S.A.

Absorption-type Merger of Seikagaku Biobusiness Corporation.


2013

CMC Laboratories established.


2018

Marketing begins for HERNICORE 1.25 Units for Intradiscal Injection in Japan.


Page Top

Copyright SEIKAGAKU CORPORATION All rights Reserved.